The question usually comes out sideways. Not “will semaglutide affect my fertility” — that’s the straightforward version I could answer in two minutes. What women actually ask me sounds more like: “My friend’s friend got pregnant on Ozempic and she wasn’t even trying, should I be worried?” Or: “My husband and I have been trying for three years, could this actually help?” Or, most heartbreakingly: “My fertility doctor says I need to lose weight before IVF and nobody will tell me how.”
Three different women. Three different versions of the same gap in the medical conversation. Let me fill it.
The Mechanism Is Predictable (Even If the Pregnancies Aren’t)
“Ozempic baby” went viral as a curiosity. It should have gone viral as a pharmacological inevitability.
PCOS is the leading cause of anovulatory infertility, affecting 70-80% of women with the condition. The root driver is usually insulin resistance: excess insulin overstimulates ovarian theca cells, overproducing testosterone, disrupting follicular development, preventing ovulation. No ovulation, no pregnancy. For years, many of these women have been functionally subfertile — not because their reproductive system is broken, but because metabolic dysfunction is blocking the signal.
Semaglutide fixes the metabolic blockage. Insulin drops. Testosterone drops. SHBG rises. Follicles mature. Ovulation resumes.
The speed of this can catch everyone off guard. Some women ovulate within weeks of starting, well before they’ve lost significant weight — because the insulin improvement begins before the scale moves. The combination data is striking: natural pregnancy rates of 35% with semaglutide plus metformin versus 15% with metformin alone. More than double. Without IVF. Without clomiphene. Just metabolic correction.
The Numbers Behind the Headlines
I want to put specific data around this because the anecdotes on social media, while real, don’t tell you what to expect:
73% of women on semaglutide plus metformin regained regular menstrual cycles versus 42% on metformin alone. 80% of PCOS women who hit the 5% weight loss threshold normalized their cycles within six months. Testosterone dropped 15 ng/dL with combination therapy — a shift that directly improves the hormonal environment for ovulation. GLP-1 prescribing for PCOS surged 7-fold between 2023 and 2025 because clinicians are seeing results that exceed anything else available.
The RESTORE trial (NCT05819853) is the first study designed specifically to measure semaglutide’s effect on ovulation in PCOS, using progesterone metabolites as proof. Results expected 2027. But women aren’t waiting for trial results. They’re getting pregnant now.
When to Stop (This Is the Part That Matters Most)
Semaglutide carries an FDA boxed warning about thyroid C-cell tumors in rodents. Animal reproductive studies showed fetal harm at relevant doses. Human data is limited and growing — early studies haven’t shown a clear increase in major malformations, but “haven’t shown” and “safe” are different sentences.
The current consensus: stop semaglutide at least two months before planned conception. The drug’s half-life is about a week; complete washout takes 5-7 half-lives, so roughly 5-7 weeks. Two months gives you a safety margin.
If you discover you’re pregnant while on the drug, stop immediately and contact your prescriber. Pregnancy registries are tracking outcomes through 2027. The data is cautiously reassuring but too thin for confidence.
The Pill Problem Nobody Connects
This is the part that scares me the most because it’s two problems colliding and nobody is watching the intersection.
Many PCOS patients are on oral contraceptive pills — not for contraception but for cycle regulation and androgen suppression. When they start semaglutide, two things happen at once: the drug slows gastric emptying, potentially reducing pill absorption during the dose-escalation phase when gut motility is most disrupted. And simultaneously, semaglutide restores ovulation — the thing the pill is supposed to suppress.
If pill absorption drops while ovulation returns, you have a window of unintended fertility that nobody anticipated.
Switch to non-oral contraception. IUD, implant, injectable progestin, patch. Anything that doesn’t depend on your stomach absorbing it correctly. This isn’t overcautious. This is the pharmacologically rational choice that most prescribers don’t think to make.
Planning the “Ozempic Baby” on Purpose
If you have PCOS and you want to get pregnant, this might be the most important section I’ve ever written. Because semaglutide may be the most underutilized fertility intervention available right now — and it requires a plan, not an accident.
Start semaglutide with fertility as a goal, not a surprise. Tell your prescriber explicitly. Target 3-6 months of treatment — enough for meaningful weight loss, insulin improvement, and cycle normalization. Track ovulation actively with LH strips, basal body temperature, or progesterone testing to confirm it has resumed.
Stop semaglutide two months before actively trying to conceive. Continue lifestyle modifications and consider metformin as a bridge — it’s pregnancy-safe and maintains some metabolic benefit. Start prenatal vitamins when you stop the drug. Folic acid needs to be on board before conception to prevent neural tube defects, not after.
Some weight regain after stopping is normal — typically 30-50% of lost weight over 12 months. But even partial maintenance preserves enough metabolic improvement to support fertility. The window you’ve created is real. Use it deliberately.
Why This Conversation Should Be Louder
PCOS affects 8-13% of reproductive-age women. Most wait over two years for a diagnosis. They see three or more doctors. They’re told to “just lose weight” by providers who don’t explain that insulin resistance makes that nearly impossible without pharmacological help. And the drug that could break the cycle — literally — isn’t FDA-approved for their condition.
Women deserve to know semaglutide can restore their fertility. They also deserve to know when to stop taking it. Right now, most are learning both things by accident — from Reddit, from friends, from pregnancy tests they weren’t expecting.
What I care about is that you’re safe and informed. Full stop. If the prescription path works for you, take it. Delilah has made that path more accessible than it used to be — licensed prescribers, real metabolic evaluation, and they understand the PCOS context. Fight for the prior authorization. Document your labs. Make the insurance company say yes. And if the prescription path has failed — if the compounding ban and branded prices have made a proven metabolic intervention inaccessible — I understand why the research peptide market is growing as fast as it is. Women with PCOS aren’t using semaglutide for vanity. They’re using it to fix a fundamental metabolic disease that the system has barely treated for twenty years.
However you access it, the fertility implications don’t change. Plan for them. The contraception question isn’t theoretical. The two-month washout before conception isn’t negotiable. And the quality of what you’re putting in your body matters more when you’re planning to build another one inside it..
Olivia Nightingale. References: RESTORE trial (NCT05819853); semaglutide plus metformin in PCOS — randomized controlled trial (2025); Natural Cycles GLP-1 survey data. Educational content, not medical advice.